Navigation Links
Discovery clarifies role of peptide in biological clock

A biologist at Washington University in St. Louis is giving the VIP treatment to laboratory mice in hopes of unraveling more clues about our biological clock.

VIP is not "very important person," but vasoactive intestinal polypeptide (VIP), a neuropeptide originally found in the gut, that is also made by a specialized group of neurons in the brain.

Erik Herzog, Ph.D., Washington University assistant professor of Biology in Arts & Sciences, has discovered that VIP is needed by the brain's biological clock to coordinate daily rhythms in behavior and physiology. Neurons in the biological clock, an area called the suprachiasmatic nucleus (SCN), keep 24-hour time and are normally synchronized as a well-oiled marching band coming onto the field at half time. Herzog and graduate student, Sara Aton, found that mice lacking the gene that makes VIP or lacking the receptor molecule for VIP suffer from internal de-synchrony. When they recorded the electrical activity of SCN neurons from these mice, they found that many had lost their beat while others were cycling but unable to synch to each other.

But when Herzog and Aton added VIP to the mice cells, the synchronicity was restored, showing that VIP couples pacemaker cells and drives rhythms in slave cells.

"VIP between SCN neurons is like a rubber band between the pendulums of two grandfather clocks, helping to synchronize their timing. Some researchers had proposed that knocking out VIP or the receptor for it stopped the clock," Herzog said. "We've found that the biological clock is still running, but its internal synchrony is uncoordinated. This causes irregular patterns of sleep and wake, for example."

The study was published on-line in Nature Neuroscience on March 6, 2005. Herzog's work is funded by the National Institutes of Health.

"In a light-dark schedule, these mice looked normal, but as soon as you leave off the lights, they reveal their internal de-synchrony," he sai
'"/>

Source:Washington University in St. Louis


Page: 1 2

Related biology news :

1. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
2. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
3. UCSD Discovery Shows How Embryonic Stem Cells Perform Quality Control Inspections
4. Discovery Could Lead To Novel Approaches In HIV Treatment
5. Discovery Promises Simpler Therapy for Sickle Cell Disease
6. Discovery may lead to better Candidiasis drug
7. Protein Discovery Could Unlock The Secret To Better TB Treatment
8. Eliminate Data Analysis Bottlenecks in Drug Discovery
9. Discovery of New Dopamine Action May Yield Alternative Psychiatric Drugs
10. Discovery could be key to bioterrorism defense
11. Discovery of an American salamander where it shouldnt be: Korea

Post Your Comments:
(Date:11/4/2009)...ity of North Carolina at Chapel Hill School of Med...sco have developed and experimentally tested a tec... drugs. , The researchers developed a computatio...s of all known drugs are to the naturally occurrin...se targets within the cell. In a study published t...
(Date:11/3/2009)...ore than 25 years, all attempts at culturing pearl...n unsuccessfuluntil now. For the first time, novel...ded (nucleated) and non-beaded cultured pearls fro...s from Florida Atlantic University,s Harbor Branch...o years of research and experimentation, Drs. Hcto...
(Date:11/3/2009)...as 28 percent less likely to become pregnant and h...that earned a Michigan State University professor ..., a researcher in the MSU College of Human Medicin...ductive Biology, focused on data of nearly 50,000 ...Luke,s findings, which also can be applied to wome...
Breaking Biology News(10 mins):Study points to new uses, unexpected side effects of already existing drugs 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3MSU researcher: Obesity significantly cuts odds of successful pregnancy 2Lexicon Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference 55970 1Lexicon Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference 55970 2Added Investment Into Healthcare By the Government Drives Growth in the European Hospital Information Systems Market Notes Frost 26 Sullivan 55968 1Added Investment Into Healthcare By the Government Drives Growth in the European Hospital Information Systems Market Notes Frost 26 Sullivan 55968 2Added Investment Into Healthcare By the Government Drives Growth in the European Hospital Information Systems Market Notes Frost 26 Sullivan 55968 3TrueFACS Announces the Addition of Nora Johnson and Pat Palmer of Medical Billing Advocates of America 55966 1TrueFACS Announces the Addition of Nora Johnson and Pat Palmer of Medical Billing Advocates of America 55966 2
...discovered that human embryonic stem cell lines ac...me. , The findings do not limit the utility of th...ure clinical applications, the researchers say, bu...em cell lines for genetic changes and to study how... researchers, work is described in the Sept. 4 onl...
...s in India has risen in response to a 20-fold drop...ording to an article in the Nov. 15 issue of Clini... introduction of generic drugs into the country ha...of the cheaper cost, the article states. , Many of...g in India have been unable to obtain treatment du...
... people with compromised immune systems may be fea...s, who demonstrated their approach could protect a...same population of immune cells that HIV destroys ...ren,s Hospital of Pittsburgh researchers, working ...ity of Pittsburgh and Louisiana State University, ...
Other Biology News:Embryonic stem cells accrue genetic changes 2Embryonic stem cells accrue genetic changes 3Embryonic stem cells accrue genetic changes 4HIV mortality in India drops with introduction of generic antiretroviral therapy 2New vaccine platform may fight infections with causes from influenza to bioterrorism 2New vaccine platform may fight infections with causes from influenza to bioterrorism 3
(Date:11/7/2009)...,, CAMBRIDGE, Mass., Nov. 7, Re...ochemistry scored top marks this evening, as Tim K...Song and Quan (Jack) Chen of Audubon, PA received ...e 2009 Siemens Competition in Math, Science & ...ce competition. ,, ( http://www.newscom.com/cg...
(Date:11/6/2009)...,, QUINCY, Mass., Nov. 6 Myrian...biotech developer and manufacturer of renewable b...preferred technology provider Uhde GmbH, one of th... "Uhde"), announced an alliance for the engineerin...,s biobased Succinic Acid plants based on renewabl...
(Date:11/6/2009)...,, CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Onc...lytics" or the "Company") today announced updated ...SIN(R) in patients with sarcomas metastatic to the...Connective Tissue Oncology Society Meeting held in...he poster presentation, entitled "A Phase II Study...
(Date:11/5/2009)...,, GAITHERSBURG, Md., Nov. 5 /PRNewswire-FirstC...ced its financial results for the third quarter en... of $3.6 million ($0.04 per share) for the three m...oss of $6.8 million ($0.08 per share) in the compa...eptember 30, 2009, GenVec,s net loss was $14.1 mil...
Breaking Biology Technology:Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
... 17 Poniard,Pharmaceuticals, Inc. (Nasdaq: PARD ..., today announced that its lead product candidate,...uct designation for the treatment of,small cell lu...designation,is based on a recommendation from the ...the European Medicines Agency (EMEA). Picoplatin ...
...lt announced today that,the Henry C. Witelson Ocul...ealth Centre has purchased a Personal Archive bios... in Montreal, Quebec. GenVault technology will be... in determining the mechanisms underlying eye canc...for developing new approaches for,treatment. These...
...ea Pharmaceuticals,Inc. announced today that BC De...diagnostic test, is now available from Panacea Lab...at should facilitate the identification,of recurre...ncer. Panacea,Laboratories, a division of Panacea ...aboratory Improvement Amendments of 1988 (CLIA). T...
Other Biology Technology:Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer 2Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer 3Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer 4McGill University Purchases GenVault's Personal Archive System to Manage Rare Cancer Samples 2Panacea Pharmaceuticals Announces the Availability of BC Detect(SM), a Serum- Based Diagnostic Test for Breast Cancer 2Panacea Pharmaceuticals Announces the Availability of BC Detect(SM), a Serum- Based Diagnostic Test for Breast Cancer 3Panacea Pharmaceuticals Announces the Availability of BC Detect(SM), a Serum- Based Diagnostic Test for Breast Cancer 4
Recombinant Expression of Peptides and Proteins: from rPeptide, LLC
Polypropylene microtube rotor, 24 1.5 ml + 24 0.5 ml from Thermo Scientific
Wellpro 384 from Thermo Scientific
...er consumption of reagents and increased throughpu...ltidrop 384 is an automated dispenser designed for...ing into 384- and 96-well plates.This new-generati...n easily switch from 96- to 384- well plates and d...
Biology Products: